Skip to content

AKA MEDICAL

Active
Private limited companyfounded 2024active for 2 yearsRoute de Verviers 82 B, 4845 Jalhay, BelgiumKBO/BCE: BE 1013.345.043
Summary

AKA MEDICAL has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137,474 and a net result of €135,474. The computed 12-month bankruptcy probability is 1.0% (low).

Overview

Official details

Source: KBO
Status
Active since 09-09-2024 Normal situation
Activity
“La société a pour objet l’exercice de la médecine par le ou les actionnaires…” (deed in French)From the articles, 12 activitiesNo NACE code in the KBO yet
Establishment unit
2.364.022.434 4218 Héron, since 09-09-2024
Financial year end
31 December
Peppol
Reachable since 09-02-2026

Board and ownership

Board

Financial position

68 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.0%
Annual accounts 2025
Gross margin
€248,567
Turnover
≈ €620,000
estimated
Profit
€135,474
Equity
€137,474
Total assets
€244,921
Filed on 26-06-2026, 35 days before the deadline
Score breakdownraises riskFounded in 20241 change of registered office in 24 monthslowers riskSize: total assets €244,921Figures for financial year 2025 (filed on 26-06-2026)Show the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 59% of micro companies without a NACE code
Financial strength
Strong
Solvency 81
equity 56.1% of total assets
Liquidity 50
short-term debt 31.6% · cash 11.0%
Profitability 100
return on assets 55.3%
Bankruptcy probability within 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 10-2025: 2.4% 11-2025: 2.4%● unchanged vs 10-2025 12-2025: 2.5%▲ +0.1 percentage points vs 11-2025 01-2026: 3.0%▲ +0.5 percentage points vs 12-2025 02-2026: 3.1%▲ +0.1 percentage points vs 01-2026 03-2026: 3.3%▲ +0.2 percentage points vs 02-2026 04-2026: 3.6%▲ +0.3 percentage points vs 03-2026highest value 05-2026: 3.5%▼ -0.1 percentage points vs 04-2026 06-2026: 3.5%● unchanged vs 05-2026 07-2026: 1.0%▼ -2.5 percentage points vs 06-2026 08-2026: 1.0%● unchanged vs 07-2026lowest value 09-2026: 1.0%● unchanged vs 08-2026lowest value 10-2026: 1.0%● unchanged vs 09-2026lowest value 11-2026: 1.0%● unchanged vs 10-2026lowest value
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 2.95, above the usual 1.5. Short-term debt is 31.6% and cash 11% of total assets. 43.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 48% of them on solvency, 40% on liquidity and 90% on profitability.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €244,921
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 26-06-2026)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
35 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Caution: A director leftlatest change 10-06-2026 · 1 in office 1 left View

Key facts about AKA MEDICAL

What is the company number of AKA MEDICAL?
The company number of AKA MEDICAL is 1013.345.043. The VAT number is the same number with BE in front: BE 1013.345.043.
Where is AKA MEDICAL based?
The registered office is at Route de Verviers 82 B, 4845 Jalhay.Company details
What is the legal form of AKA MEDICAL?
The legal form of AKA MEDICAL is Private limited company (BV).
When was AKA MEDICAL founded?
AKA MEDICAL was founded on 09-09-2024.
Is AKA MEDICAL still active?
Yes, AKA MEDICAL is an active enterprise in the KBO register.
What is the turnover of AKA MEDICAL?
The turnover in financial year 2025 is ≈ €620,000. This figure is estimated from the gross margin of €248,567 and 2,213 comparable companies of the same size. It probably lies between €420,000 and €960,000. It is a rough estimate.Financials
Is AKA MEDICAL profitable?
In financial year 2025, AKA MEDICAL made a profit of €135,474.
Where can I find the annual accounts of AKA MEDICAL?
AKA MEDICAL filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.